134 related articles for article (PubMed ID: 36328194)
21. miR‑32‑5p suppresses the proliferation and migration of pancreatic adenocarcinoma cells by targeting TLDC1.
Yuan P; Tang C; Chen B; Lei P; Song J; Xin G; Wang Z; Hui Y; Yao W; Wang G; Zhao G
Mol Med Rep; 2021 Nov; 24(5):. PubMed ID: 34468015
[TBL] [Abstract][Full Text] [Related]
22. Synthesis and evaluation of tiaprofenic acid-derived UCHL5 deubiquitinase inhibitors.
Gurusingha Arachchige HS; Herath Mudiyanselage PDH; VanHecke GC; Patel K; Cheaito HA; Dou QP; Ahn YH
Bioorg Med Chem; 2021 Jan; 30():115931. PubMed ID: 33341501
[TBL] [Abstract][Full Text] [Related]
23. CSTF2T facilitates pancreatic adenocarcinoma growth and metastasis by elevating H3K4Me1 methylation of CALB2 via ASH2L.
Liu W; Hu D; Li J; Xu Q; Chen Z; Xu B
Cancer Biol Ther; 2023 Dec; 24(1):2216041. PubMed ID: 37287122
[TBL] [Abstract][Full Text] [Related]
24. Overexpressed CA12 has prognostic value in pancreatic cancer and promotes tumor cell apoptosis via NF-κB signaling.
Du Y; Xin Z; Liu T; Xu P; Mao F; Yao J
J Cancer Res Clin Oncol; 2021 May; 147(5):1557-1564. PubMed ID: 33387040
[TBL] [Abstract][Full Text] [Related]
25. Identification of a Four Cancer Stem Cell-Related Gene Signature and Establishment of a Prognostic Nomogram Predicting Overall Survival of Pancreatic Adenocarcinoma.
Li S; Chen R; Luo W; Lin J; Chen Y; Wang Z; Lin W; Li B; Wang J; Yang J
Comb Chem High Throughput Screen; 2022; 25(12):2070-2081. PubMed ID: 35048799
[TBL] [Abstract][Full Text] [Related]
26. LINC00941 promotes proliferation and metastasis of pancreatic adenocarcinoma by competitively binding miR-873-3p and thus upregulates ATXN2.
Fang L; Wang SH; Cui YG; Huang L
Eur Rev Med Pharmacol Sci; 2021 Feb; 25(4):1861-1868. PubMed ID: 33660796
[TBL] [Abstract][Full Text] [Related]
27. [Influence of UCHL5 on proliferation and apoptosis of SW527 breast cancer cells].
Ding F; Ma JL; Wu XW; Liu ZH
Zhonghua Zhong Liu Za Zhi; 2018 Dec; 40(12):900-904. PubMed ID: 30605979
[No Abstract] [Full Text] [Related]
28. ARHGAP25 Inhibits Pancreatic Adenocarcinoma Growth by Suppressing Glycolysis via AKT/mTOR Pathway.
Huang WK; Chen Y; Su H; Chen TY; Gao J; Liu Y; Yeh CN; Li S
Int J Biol Sci; 2021; 17(7):1808-1820. PubMed ID: 33994864
[TBL] [Abstract][Full Text] [Related]
29. LINC01106 post-transcriptionally regulates ELK3 and HOXD8 to promote bladder cancer progression.
Meng L; Xing Z; Guo Z; Liu Z
Cell Death Dis; 2020 Dec; 11(12):1063. PubMed ID: 33311496
[TBL] [Abstract][Full Text] [Related]
30. Novel necroptosis-related gene signature for predicting the prognosis of pancreatic adenocarcinoma.
Wu Z; Huang X; Cai M; Huang P; Guan Z
Aging (Albany NY); 2022 Jan; 14(2):869-891. PubMed ID: 35077391
[TBL] [Abstract][Full Text] [Related]
31. LINC00662 promotes cell proliferation, migration and invasion of melanoma by sponging miR-890 to upregulate ELK3.
Xia XQ; Lu WL; Ye YY; Chen J
Eur Rev Med Pharmacol Sci; 2020 Aug; 24(16):8429-8438. PubMed ID: 32894549
[TBL] [Abstract][Full Text] [Related]
32. Long Non-Coding RNA LINC00525 Promotes the Stemness and Chemoresistance of Colorectal Cancer by Targeting miR-507/ELK3 Axis.
Wang S; Li J; Yang X
Int J Stem Cells; 2019 Jul; 12(2):347-359. PubMed ID: 31242722
[TBL] [Abstract][Full Text] [Related]
33. Impact of Losing hRpn13 Pru or UCHL5 on Proteasome Clearance of Ubiquitinated Proteins and RA190 Cytotoxicity.
Osei-Amponsa V; Sridharan V; Tandon M; Evans CN; Klarmann K; Cheng KT; Lack J; Chari R; Walters KJ
Mol Cell Biol; 2020 Aug; 40(18):. PubMed ID: 32631902
[TBL] [Abstract][Full Text] [Related]
34. The deubiquitinase UCHL5/UCH37 positively regulates Hedgehog signaling by deubiquitinating Smoothened.
Zhou Z; Yao X; Pang S; Chen P; Jiang W; Shan Z; Zhang Q
J Mol Cell Biol; 2018 Jun; 10(3):243-257. PubMed ID: 28992318
[TBL] [Abstract][Full Text] [Related]
35. Increased expression of zinc transporter ZIP4, ZIP11, ZnT1, and ZnT6 predicts poor prognosis in pancreatic cancer.
Zhu B; Huo R; Zhi Q; Zhan M; Chen X; Hua ZC
J Trace Elem Med Biol; 2021 May; 65():126734. PubMed ID: 33631610
[TBL] [Abstract][Full Text] [Related]
36. Development and Validation of an Inflammatory Response-Related Gene Signature for Predicting the Prognosis of Pancreatic Adenocarcinoma.
Deng ZL; Zhou DZ; Cao SJ; Li Q; Zhang JF; Xie H
Inflammation; 2022 Aug; 45(4):1732-1751. PubMed ID: 35322324
[TBL] [Abstract][Full Text] [Related]
37. ETS transcription factor ELK3 in human cancers: An emerging therapeutic target.
Al-Hawary SIS; Pallathadka H; Hjazi A; Zhumanov ZE; Alazbjee AAA; Imad S; Alsalamy A; Hussien BM; Jaafer NS; Mahmoudi R
Pathol Res Pract; 2023 Aug; 248():154728. PubMed ID: 37542863
[TBL] [Abstract][Full Text] [Related]
38. LINC01232 exerts oncogenic activities in pancreatic adenocarcinoma via regulation of TM9SF2.
Li Q; Lei C; Lu C; Wang J; Gao M; Gao W
Cell Death Dis; 2019 Sep; 10(10):698. PubMed ID: 31541081
[TBL] [Abstract][Full Text] [Related]
39. Development and validation of a novel N6-methyladenosine (m6A)-related multi- long non-coding RNA (lncRNA) prognostic signature in pancreatic adenocarcinoma.
Yuan Q; Ren J; Li L; Li S; Xiang K; Shang D
Bioengineered; 2021 Dec; 12(1):2432-2448. PubMed ID: 34233576
[TBL] [Abstract][Full Text] [Related]
40. NQO1/CPT1A promotes the progression of pancreatic adenocarcinoma via fatty acid oxidation.
Xu R; Liu Y; Ma L; Sun Y; Liu H; Yang Y; Jin T; Yang D
Acta Biochim Biophys Sin (Shanghai); 2023 May; 55(5):758-768. PubMed ID: 37249337
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]